Design and development of a mucoadhesive buccal film bearing progesterone

Pharmazie

Volumn 63, Issue 2, 2008, Pages 129-135

  Jain, Sanjay K ^a   Jain, A ^a   Gupta, Y ^a   Kharya, A ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; POLYMER; POVIDONE; PROGESTERONE;

ADHESION; ADULT; ARTICLE; CHEEK MUCOSA; DENSITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG RELEASE; FEMALE; FILM; HUMAN; HUMAN EXPERIMENT; INFRARED SPECTROSCOPY; MALE; NORMAL HUMAN; PH; SCANNING ELECTRON MICROSCOPE; SURFACE PROPERTY; X RAY DIFFRACTION;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HYDROGEN-ION CONCENTRATION; MICROSCOPY, ELECTRON, SCANNING; MOUTH MUCOSA; PROGESTERONE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES; SWINE; TISSUE ADHESIVES; X-RAY DIFFRACTION;

EID: 39449139281     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.7114     Document Type: Article

References (29)

1. Artursson P, Lindmark T, Davis SS, Illum L (1994) Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res 11: 1358-1361.
2. Artusi M, Santi P, Colombo P, Junginger HE (2003) Buccal delivery of thiocolchicoside: in vitro and in vivo permeation studies. Int J Pharm 250: 203-213.
3. Bernkop-Schnürch A (2000) Chitosan and its derivatives: potential excipients for peroral peptide delivery systems. Int J Pharm 194: 1-13.
4. Bottenberg P, Cleymaet R, Muyncha CD, Remon JP, Coomans D, Slop D (1992) Comparison of salivary fluoride concentration after administration of bioadhesive slow-release tablet and a conventional fluoride tablet. J Pharm Pharmacol 44: 684-686.
5. Columbia Laboratories Inc., http://www.columbialabs.com/Crinone® 4% and 8% (progesterone gel). URL: http://www.crinoneus.com/ Crinone_Package_Insert_Physicians.pdf. Accessed on 13.06.07.
6. Dodane V, Amin Khan A, Mervin JR (1999) Effect of chitosan on epithelial permeability and structure. Int J Pharm 182: 21-32.
7. Eouani C, Piccerelle P, Prinderre P, Bourret E, Joachim J (2001) In vitro comparative study of buccal mucoadhesive performance of different polymeric films. Eur J Pharm Biopharm 52: 45-55.
8. Hamman JH, Stander M, Kotze AF (2002) Effect of the degree of quaternization of N-trimethyl chitosan chloride on absorption enhancement: in vivo evaluation in rat nasal epithelia. Int J Pharm 232: 235-242.
9. Han R, Fang J, Sung KC, Hu OYP (1999) Mucoadhesive buccal disks for novel nalbuphine prodrug controlled delivery: effect of formulation variables on drug release and mucoadhesive performance. Int J Pharm 177: 201-209.
10. Han, Myeong-Jin (2000) Biodegradable membranes for the controlled release of progesterone. 1. Characterization of membrane morphologies coagulated from PLGA/progesterone/DMF solutions. J Appl Poly Sci 75: 60-67.
11. Henriksen I, Green KL, Smart JD, Smistad G, Karlsen J (1996) Bioadhesion of hydrated chitosans: an in vitro and in vivo study. Int J Pharm 145: 231-240.
12. Jain SK, Chourasia MK, Masuriha R, Soni V, Jain A, Jain NK, Gupta Y (2005) Solid lipid nanoparticles bearing flurbiprofen for transdermal delivery. Drug Delivery 12: 207-215.
13. Jones DS, Woolfson AD, Brown AF, Coulter WA, Mc Clelland C, Irwin CR (2000) Design, characterization and preliminary clinical evaluation of a novel mucoadhesive topical formulation containing tetracycline for the treatment of periodontal disease. J Control Release 67: 357-368.
14. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA (1983) Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 15: 25-35.
15. Langoth N, Kalbe J, Bernkop-Schnurch A (2005) Development of a mucoadhesive and permeation enhancing buccal delivery system for PACAP (pituitary adenylate cyclase-activating polypeptide). Int J Pharm 296: 103-111.
16. Lee JW, Park J, Robinson H (2000) Bioadhesive-based dosage forms: the next generation. J Pharm Sci 89: 850-866.
17. Nafee NA, Ismail FA, Boraie NA, Mortada LM (2003) Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing. Int J Pharm 264: 1-14.
18. Nair MK, Chien YW (1996) Development of anticandidal delivery systems. (II) Mucoadhesive devices for prolonged drug delivery in the oral cavity. Drug Dev Ind Pharm 22: 243-253.
19. Okamoto H, Taguchi H, Iida K, Danjio K (2001) Development of polymer film dosage forms of lidocaine for buccal administration. I. Penetration rate and release rate. J Control Release 77: 253-260.
20. Peh KK, Wong CF (1999) Polymeric films as a vehicle for buccal delivery: swelling, mechanical and bioadhesive properties. J Pharm Pharm Sci 2: 53-61.
21. Perioli L, Ambrogi V, Angelici F, Ricci M, Giovagnoli S, Capuccella M, Rossi C (2004) Development of mucoadhesive patches for buccal administration of ibuprofen. J Control Rel 99: 73-82.
22. Rossi S, Sandri G, Ferrari F, Bonferoni MC, Caramella C (2003a) Buccal delivery of acyclovir from films based on chitosan and polyacrylic acid. Drug Dev Ind Pharm 8: 199-203.
23. Rossi S, Sandri G, Ferrari F, Bonferoni MC, Caramella C (2003b) Development of films and matrices based on chitosan and polyacrylic acid for vaginal delivery of acyclovir. STP Pharm Sci 13: 183-190.
24. Samuelov Y, Donbrow M, Friedman M (1979) Sustained release of drugs from ethyl cellulose-polyethylene glycol films and kinetics of drug release. J Pharm Sci 68: 325-329.
25. Senel S, Hincal AA (2001) Drug permeation enhancement via buccal route: possibilities and limitations. J Control Release 72: 133-144.
26. Senel S, Ikinci G, Kas S, Yousefi-Rad A, Sargon MF, Hincal AA (2000) Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery. Int J Pharm 193: 197-203.
27. Shin SC, Bum JP, Choi JS (2000) Enhanced bioavailability by buccal administration of triamcinolone acetonide from the bioadhesive gels in rabbits. Int J Pharm 209: 37-43.
28. Vaugelade C, Rohmer A-C, Burel F, Belleney J, Duclos R, Bunel C (2001) Progesterone freeze-dried systems in sublingual dosage form. Int J Pharm 229: 67-73.
29. Wong CF, Yen KH, Peh KK (1999) Formulation and evaluation of controlled release Eudragit buccal patches. Int J Pharm 178: 11-22.